1
|
Amrenova A, Baudin C, Ostroumova E, Stephens J, Anderson R, Laurier D. Intergenerational effects of ionizing radiation: review of recent studies from human data (2018-2021). Int J Radiat Biol 2024:1-11. [PMID: 38319708 DOI: 10.1080/09553002.2024.2309917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Accepted: 01/16/2024] [Indexed: 02/07/2024]
Abstract
PURPOSE The purpose of this paper was to conduct a review of the studies published between 2018 and 2022 to investigate radiation-related effects in the offspring of human individuals exposed to ionizing radiation. METHODS The search identified 807 publications, from which 9 studies were selected for detailed analysis to examine for effects in children whose parents were exposed to various types and doses of radiation. RESULTS The review does not yield substantial evidence supporting intergenerational effects of radiation exposure in humans. However, caution is required when interpreting the results due to limitations in the majority of the published articles. CONCLUSION This review, covering the period 2018-2022, serves as an extension of the previous systematic review conducted by Stephens et al. (2024), which encompassed the years 1988-2018. Together, these two papers offer a comprehensive overview of the available evidence regarding the intergenerational effects of parental pre-conceptional exposure to ionizing radiation. Overall, the findings do not provide strong evidence supporting a significant association between adverse (or other) outcomes in unexposed children and parental preconception radiation exposure.
Collapse
Affiliation(s)
- A Amrenova
- Health and Environment Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay aux Roses, France
| | - C Baudin
- Health and Environment Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay aux Roses, France
| | - E Ostroumova
- International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - J Stephens
- Centre for Health Effects of Radiological and Chemical Agents, Department of Life Sciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, UK
| | - R Anderson
- Centre for Health Effects of Radiological and Chemical Agents, Department of Life Sciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, UK
| | - D Laurier
- Health and Environment Division, Institute for Radiological Protection and Nuclear Safety (IRSN), Fontenay aux Roses, France
| |
Collapse
|
2
|
Drozdovitch V, Yauseyenka VV, Minenko VF, Veyalkin IV, Kukhta TS, Grakovitch RI, Trofimik S, Polyanskaya ON, Starastsenka L, Cahoon EK, Hatch M, Little MP, Brenner AV, Ostroumova E, Mabuchi K, Rozhko AV. THYROID SCREENING AND RELIABILITY OF RADIATION THYROID DOSES FOR THE BELARUSIAN IN UTERO COHORT. Probl Radiac Med Radiobiol 2021; 26:188-198. [PMID: 34965548 PMCID: PMC9476699 DOI: 10.33145/2304-8336-2021-26-188-198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/11/2021] [Indexed: 06/14/2023]
Abstract
OBJECTIVE To describe the status and results of thyroid disease screening and assessment of reliability of radiationthyroid doses in the Belarusian in utero cohort of 2,965 individuals exposed to Chernobyl (Chornobyl) fallout. MATERIALS AND METHODS Thyroid screening examinations are currently underway including thyroid palpation by anendocrinologist, ultrasonographic examination by an ultrasonographer and analysis of blood samples for diagnosisof hypo- and hyperthyroidism, autoimmune thyroiditis, thyroid function tests (thyroid-stimulating hormone [TSH],thyroxine [T4], thyroid peroxidase antibody [anti-TPO], and thyroglobulin antibodies [anti-TG]). Reliability of (i)information from 780 pairs of questionnaires obtained during the first and second interviews of the mothers and (ii)thyroid doses, which were calculated for the cohort members using this information, is evaluated. RESULTS As of 15 August 2021, 1,267 in utero exposed study subjects had been screened. A single thyroid nodule wasdiagnosed in 167 persons (13.2 % of the total) and multiple thyroid nodules in 101 persons (8.0 %): 189 (14.9 %)persons had nodules detected for the first time at the screening while 79 (6.2 %) persons had nodules detected pre-viously (pre-screening nodules). Fifty-nine out of 268 subjects (22.0 %) with a suspicious thyroid nodule werereferred to fine needle aspiration biopsy, and among them 33 (55.9 %) were biopsied. Reasonable agreement wasobserved for modelqbased doses calculated for the Belarusian in utero cohort members using data from the two inter-views (Spearman's rank-correlation coefficient rs = 0.74, p < 0.001), while measurementqbased doses yielded almost per-fect agreement (rs = 0.99, p < 0.001). CONCLUSIONS During the thyroid screening, at least one thyroid nodule was identified in 268 of 1,267 (21.2 %) inutero exposed cohort members. Seven thyroid cancer cases were identified in the cohort, including 5 pre-screeningcases and 2 cases detected during the screening. Ongoing research on this unique cohort will provide importantinformation on adverse health effects following prenatal and postnatal exposure to radioiodine and radiocesium iso-topes, for which available epidemiological data are scant.
Collapse
Affiliation(s)
- V Drozdovitch
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - V V Yauseyenka
- Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus
| | - V F Minenko
- Institute for Nuclear Problems, Belarusian State University, 11 Bobruiskaya Street, Minsk, 220006, Belarus
| | - I V Veyalkin
- Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus
| | - T S Kukhta
- Joint Institute of Informatics Problems, National Academy of Sciences of Belarus, 6 Surhanava Street, Minsk, 220012, Belarus
| | - R I Grakovitch
- Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus
| | - S Trofimik
- Institute for Nuclear Problems, Belarusian State University, 11 Bobruiskaya Street, Minsk, 220006, Belarus
| | - O N Polyanskaya
- Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus
| | - L Starastsenka
- Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus
| | - E K Cahoon
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - M Hatch
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - M P Little
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - A V Brenner
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - E Ostroumova
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - K Mabuchi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD 20892-9778, USA
| | - A V Rozhko
- Republican Research Center for Radiation Medicine and Human Ecology, 290 Ilyicha Street, Gomel, 246040, Belarus
| |
Collapse
|
3
|
Schüz J, Kovalevskiy E, Moissonnier M, Olsson A, Hashim D, Kromhout H, Kashanskiy S, Chernov O, Bukhtiyarov I, Ostroumova E. Comparison of Two Information Sources for Cause-of-Death Follow-up in the Russian Federation: The Asbest Chrysotile Cohort Study. Methods Inf Med 2020; 59:9-17. [PMID: 32535878 PMCID: PMC7446113 DOI: 10.1055/s-0040-1710381] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 03/26/2020] [Indexed: 10/28/2022]
Abstract
BACKGROUND The Asbest chrysotile cohort was set up in Asbest town, Sverdlovsk oblast, Russian Federation, among the current and former workforce of the world's largest operating chrysotile mine and its processing mills, to investigate cancer risk in relation to occupational exposure to chrysotile. OBJECTIVES The cohort of 35,837 people was followed-up for mortality using cause-of-death information from official death certificates issued by the Civil Act Registration Office (ZAGS) of Sverdlovsk oblast from 1976 to 2015. Data were also retrieved from the electronic cause-of-death registry of the Medical Information Analytical Centre (MIAC) of Sverdlovsk oblast, which was launched in 1990 and operates independently of ZAGS. The objectives were to compare the completeness of record linkage (RL) with ZAGS and with MIAC, and to compare the agreement of cause-of-death information obtained from ZAGS and from MIAC, with a focus on malignant neoplasms. METHODS RL completeness of identifying cohort members in ZAGS and in MIAC was compared for the period 1990 to 2015. In the next step, for the comparison of the retrieved cause-of-death information, 5,463 deaths (1,009 from cancer) were used that were registered in 2002 to 2015, when causes of death were coded using International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10) nomenclature by MIAC. For ZAGS, original cause-of-death text from the death certificates was obtained and then coded according to ICD-10 by the International Agency for Research on Cancer/World Health Organization (IARC/WHO). Agreement was evaluated at various levels of detail, and reasons for any disagreements between the MIAC and the IARC/WHO ICD-10-coded cancer diagnosis were systematically explored. RESULTS A total of 10,886 deaths were obtained from all avenues of follow-up for the period 1990 to 2015 in the cohort; 10,816 (99.4%) of these were found in ZAGS. This percentage was 88.3% if only automated deterministic RL was used and 99.4% when deterministic RL was complemented with manual searches of cohort members. Comparison of the cause-of-death information showed agreement of 97.9% at the ICD-10 main group level between ZAGS (coded by IARC/WHO) and MIAC. Of 1,009 cancer deaths, 679 (67.3%) cases had identical coding, 258 (25.6%) cases corresponded at the three-character ICD-10 level, 36 (3.6%) had codes that were within the same anatomical or morphological cluster, and for only 36 (3.6%) cases were major discrepancies identified. Altogether, the agreement between IARC/WHO coding of cause-of-death information from ZAGS and MIAC coding of malignant neoplasms was therefore 96.4%. CONCLUSIONS RL completeness and agreement of cause-of-death information obtained from ZAGS and from MIAC were both very high. This is reassuring for the quality of cancer mortality follow-up of the Asbest chrysotile cohort. For future epidemiological studies in the Russian Federation, ZAGS appears to be a reliable information source for mortality follow-up, if the automated RL is complemented with manual searches of cohort members. MIAC is a good resource for prospective studies.
Collapse
Affiliation(s)
- J. Schüz
- Section of Environment and Radiation, International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - E. Kovalevskiy
- Federal State Budgetary Scientific Institution “Izmerov Research Institute of Occupational Health,” Moscow, Russian Federation
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
| | - M. Moissonnier
- Section of Environment and Radiation, International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - A. Olsson
- Section of Environment and Radiation, International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - D. Hashim
- Section of Environment and Radiation, International Agency for Research on Cancer (IARC/WHO), Lyon, France
| | - H. Kromhout
- Institute of Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands
| | - S. Kashanskiy
- Yekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, Yekaterinburg, Russian Federation
| | - O. Chernov
- Federal State Budgetary Scientific Institution “Izmerov Research Institute of Occupational Health,” Moscow, Russian Federation
| | - I. Bukhtiyarov
- Federal State Budgetary Scientific Institution “Izmerov Research Institute of Occupational Health,” Moscow, Russian Federation
- I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
| | - E. Ostroumova
- Section of Environment and Radiation, International Agency for Research on Cancer (IARC/WHO), Lyon, France
| |
Collapse
|
4
|
Apsalikov KN, Lipikhina A, Grosche B, Belikhina T, Ostroumova E, Shinkarev S, Stepanenko V, Muldagaliev T, Yoshinaga S, Zhunussova T, Hoshi M, Katayama H, Lackland DT, Simon SL, Kesminiene A. The State Scientific Automated Medical Registry, Kazakhstan: an important resource for low-dose radiation health research. Radiat Environ Biophys 2019; 58:1-11. [PMID: 30446811 DOI: 10.1007/s00411-018-0762-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/13/2018] [Accepted: 11/07/2018] [Indexed: 06/09/2023]
Abstract
Direct quantitative assessment of health risks following exposure to ionizing radiation is based on findings from epidemiological studies. Populations affected by nuclear bomb testing are among those that allow such assessment. The population living around the former Soviet Union's Semipalatinsk nuclear test site is one of the largest human cohorts exposed to radiation from nuclear weapons tests. Following research that started in the 1960s, a registry that contains information on more than 300,000 individuals residing in the areas neighboring to the test site was established. Four nuclear weapons tests, conducted from 1949 to 1956, resulted in non-negligible radiation exposures to the public, corresponding up to approximately 300 mGy external dose. The registry contains relevant information about those who lived at the time of the testing as well as about their offspring, including biological material. An international group of scientists worked together within the research project SEMI-NUC funded by the European Union, and concluded that the registry provides a novel, mostly unexplored, and valuable resource for the assessment of the population risks associated with environmental radiation exposure. Suggestions for future studies and pathways on how to use the best dose assessment strategies have also been described in the project. Moreover, the registry could be used for research on other relevant public health topics.
Collapse
Affiliation(s)
- K N Apsalikov
- Scientific Research Institute for Radiation Medicine and Ecology, 258 Gagarina Street, Semey, 490007, Kazakhstan
| | - A Lipikhina
- Scientific Research Institute for Radiation Medicine and Ecology, 258 Gagarina Street, Semey, 490007, Kazakhstan
| | - B Grosche
- Federal Office for Radiation Protection, Neuherberg, Germany.
- , Grasmückenweg 19, 85356, Freising, Germany.
| | - T Belikhina
- Scientific Research Institute for Radiation Medicine and Ecology, 258 Gagarina Street, Semey, 490007, Kazakhstan
| | - E Ostroumova
- International Agency for Research on Cancer, 150 Cours Albert Thomas, 96372, Lyon Cedex 08, France
| | - S Shinkarev
- State Research Center-Burnasyan Federal Medical Biophysical Center, 46 Zhivopisnaya Street, Moscow, 123182, Russian Federation
| | - V Stepanenko
- A. Tsyb Medical Radiological Research Center, 4, Koroleva Street, Obninsk, 249036, Russian Federation
| | - T Muldagaliev
- Scientific Research Institute for Radiation Medicine and Ecology, 258 Gagarina Street, Semey, 490007, Kazakhstan
| | - S Yoshinaga
- Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima, 734-8553, Japan
| | - T Zhunussova
- Norwegian Radiation Protection Authority, Grini Naeringspark 13, 1332, Osteraas, Norway
| | - M Hoshi
- Institute for Peace Science, Hiroshima University, Higashisenda-machi 1-1-89, Naka-ku, Hiroshima, 730-0053, Japan
| | - H Katayama
- The Comprehensive Data Archives and Analysis (CDAA), 6-7, Hacchobori, Naka-ku, Hiroshima, 730-0013, Japan
| | - D T Lackland
- Medical University of South Carolina, 19 Hagood Ave, Charleston, SC, 29425-8350, USA
| | - S L Simon
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Bethesda, MD, 20892-9778, USA
| | - A Kesminiene
- International Agency for Research on Cancer, 150 Cours Albert Thomas, 96372, Lyon Cedex 08, France
| |
Collapse
|
5
|
Hatch M, Ostroumova E, Brenner A, Federenko Z, Gorokh Y, Zvinchuk O, Shpak V, Tereschenko V, Tronko M, Mabuchi K. Non-thyroid cancer in Northern Ukraine in the post-Chernobyl period: Short report. Cancer Epidemiol 2015; 39:279-83. [PMID: 25794878 DOI: 10.1016/j.canep.2015.02.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2014] [Revised: 02/13/2015] [Accepted: 02/16/2015] [Indexed: 11/24/2022]
Abstract
The Chernobyl nuclear power plant accident in Ukraine in 1986 led to widespread radioactive releases into the environment - primarily of radioiodines and cesium - heavily affecting the northern portions of the country, with settlement-averaged thyroid doses estimated to range from 10 mGy to more than 10 Gy. The increased risk of thyroid cancer among exposed children and adolescents is well established but the impact of radioactive contamination on the risk of other types of cancer is much less certain. To provide data on a public health issue of major importance, we have analyzed the incidence of non-thyroid cancers during the post-Chernobyl period in a well-defined cohort of 13,203 individuals who were <18 years of age at the time of the accident. The report is based on standardized incidence ratio (SIR) analysis of 43 non-thyroid cancers identified through linkage with the National Cancer Registry of Ukraine for the period 1998 through 2009. We compared the observed and expected number of cases in three cancer groupings: all solid cancers excluding thyroid, leukemia, and lymphoma. Our analyses found no evidence of a statistically significant elevation in cancer risks in this cohort exposed at radiosensitive ages, although the cancer trends, particularly for leukemia (SIR=1.92, 95% confidence interval: 0.69; 4.13), should continue to be monitored.
Collapse
Affiliation(s)
- M Hatch
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
| | - E Ostroumova
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - A Brenner
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Z Federenko
- National Cancer Registry of Ukraine, National Cancer Institute, Kiev, Ukraine
| | - Y Gorokh
- National Cancer Registry of Ukraine, National Cancer Institute, Kiev, Ukraine
| | - O Zvinchuk
- Institute of Endocrinology and Metabolism, Kiev, Ukraine
| | - V Shpak
- Institute of Endocrinology and Metabolism, Kiev, Ukraine
| | - V Tereschenko
- Institute of Endocrinology and Metabolism, Kiev, Ukraine
| | - M Tronko
- Institute of Endocrinology and Metabolism, Kiev, Ukraine
| | - K Mabuchi
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| |
Collapse
|
6
|
Hatch M, Furukawa K, Brenner A, Olinjyk V, Ron E, Zablotska L, Terekhova G, McConnell R, Markov V, Shpak V, Ostroumova E, Bouville A, Tronko M. Prevalence of hyperthyroidism after exposure during childhood or adolescence to radioiodines from the chornobyl nuclear accident: dose-response results from the Ukrainian-American Cohort Study. Radiat Res 2010; 174:763-72. [PMID: 21128800 DOI: 10.1667/rr2003.1] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Relatively few data are available on the prevalence of hyperthyroidism (TSH concentrations of <0.3 mIU/liter, with normal or elevated concentrations of free T4) in individuals exposed to radioiodines at low levels. The accident at the Chornobyl (Chernobyl) nuclear plant in Ukraine on April 26, 1986 exposed large numbers of residents to radioactive fallout, principally to iodine-131 ((131)I) (mean and median doses = 0.6 Gy and 0.2 Gy). We investigated the relationship between (131)I and prevalent hyperthyroidism among 11,853 individuals exposed as children or adolescents in Ukraine who underwent an in-depth, standardized thyroid gland screening examination 12-14 years later. Radioactivity measurements taken shortly after the accident were available for all subjects and were used to estimate individual thyroid doses. We identified 76 cases of hyperthyroidism (11 overt, 65 subclinical). Using logistic regression, we tested a variety of continuous risk models and conducted categorical analyses for all subjects combined and for females (53 cases, n = 5,767) and males (23 cases, n = 6,086) separately but found no convincing evidence of a dose-response relationship between (131)I and hyperthyroidism. There was some suggestion of elevated risk among females in an analysis based on a dichotomous dose model with a threshold of 0.5 Gy chosen empirically (OR = 1.86, P = 0.06), but the statistical significance level was reduced (P = 0.13) in a formal analysis with an estimated threshold. In summary, after a thorough exploration of the data, we found no statistically significant dose-response relationship between individual (131)I thyroid doses and prevalent hyperthyroidism.
Collapse
Affiliation(s)
- M Hatch
- Division of Cancer Epidemiology and Genetics, NCI/NIH/DHHS, Rockville, Maryland 20852, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Eidemüller M, Ostroumova E, Krestinina L, Epiphanova S, Akleyev A, Jacob P. Comparison of mortality and incidence solid cancer risk after radiation exposure in the Techa River Cohort. Radiat Environ Biophys 2010; 49:477-490. [PMID: 20461395 DOI: 10.1007/s00411-010-0289-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2009] [Accepted: 04/17/2010] [Indexed: 05/29/2023]
Abstract
In the present paper, analysis of solid cancer mortality and incidence risk after radiation exposure in the Techa River Cohort in the Southern Urals region of Russia is described. Residents along the Techa River received protracted exposure to ionizing radiation in the 1950s due to the releases of radioactive materials from the Mayak Production Association. The current follow-up through December 2003 includes individuals exposed on the Techa riverside within the Chelyabinsk and Kurgan oblasts using mortality data, and within the Chelyabinsk oblast using incidence data. The analysis was performed by means of the biologically based two-stage clonal expansion (TSCE) model and conventional excess relative risk models. For the mortality and incidence cohorts, central estimates of the excess relative risk per dose of 0.85 Gy(-1) (95% CI 0.36; 1.38) and 0.91 Gy(-1) (95% CI 0.35; 1.52) were found, respectively. For both the mortality and incidence cohorts, the best description of the radiation risk was achieved with the same TSCE model including a lifelong radiation effect on the promotion rate of initiated cells. An increase in the excess risk with attained age was observed, whereas no significant change of risk with age at exposure was seen. Direct comparison of the mortality and incidence cohorts showed that the excess relative risk estimates agreed very well in both cohorts, as did the excess absolute risk and the hazard after correction for the different background rates.
Collapse
Affiliation(s)
- M Eidemüller
- Helmholtz Zentrum München, Institute of Radiation Protection, 85764 Neuherberg, Germany.
| | | | | | | | | | | |
Collapse
|
8
|
Hatch M, Brenner A, Bogdanova T, Derevyanko A, Kuptsova N, Likhtarev I, Bouville A, Tereshchenko V, Kovgan L, Shpak V, Ostroumova E, Greenebaum E, Zablotska L, Ron E, Tronko M. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab 2009; 94:899-906. [PMID: 19106267 PMCID: PMC2681280 DOI: 10.1210/jc.2008-2049] [Citation(s) in RCA: 48] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/18/2008] [Accepted: 12/12/2008] [Indexed: 11/19/2022]
Abstract
BACKGROUND Like stable iodine, radioiodines concentrate in the thyroid gland, increasing thyroid cancer risk in exposed children. Data on exposure to the embryonic/fetal thyroid are rare, raising questions about use of iodine 131 (I-131) in pregnant women. We present here estimated risks of thyroid disease from exposure in utero to I-131 fallout from the Chernobyl nuclear accident. METHODS We conducted a cross-sectional thyroid screening study (palpation, ultrasound, thyroid hormones, and, if indicated, fine needle aspiration) from 2003 to 2006. Participants were 2582 mother-child pairs from Ukraine in which the mother had been pregnant at the time of the accident on April 26, 1986, or 2 months after the time during which I-131 fallout was still present (1494 from contaminated areas, 1088 in the comparison group). Individual cumulative in utero thyroid dose estimates were derived from estimated I-131 activity in the mother's thyroid (mean 72 mGy; range 0-3230 mGy). RESULTS There were seven cases of thyroid carcinoma and one case of Hurthle cell neoplasm identified as a result of the screening. Whereas the estimated excess odds ratio per gray for thyroid carcinoma was elevated (excess odds ratio per gray 11.66), it was not statistically significant (P = 0.12). No radiation risks were identified for other thyroid diseases. CONCLUSION Our results suggest that in utero exposure to radioiodines may have increased the risk of thyroid carcinoma approximately 20 yr after the Chernobyl accident, supporting a conservative approach to medical uses of I-131 during pregnancy.
Collapse
Affiliation(s)
- M Hatch
- Chernobyl Research Unit, Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Boulevard, EPS 7098, Rockville, Maryland 20852, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
9
|
Eidemüller M, Ostroumova E, Krestinina L, Akleyev A, Jacob P. Analysis of solid cancer mortality in the techa river cohort using the two-step clonal expansion model. Radiat Res 2008; 169:138-48. [PMID: 18220471 DOI: 10.1667/rr1157.1] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2007] [Accepted: 10/02/2007] [Indexed: 11/03/2022]
Abstract
In this study the solid cancer mortality data in the Techa River Cohort in the Southern Urals region of Russia was analyzed. The cohort received protracted exposure in the 1950s due to the releases of radioactive materials from the Mayak plutonium complex. The Extended Techa River Cohort includes 29,849 people who resided along the Techa River between 1950 and 1960 and were followed from January 1, 1950 through December 31, 1999. The analysis was done within the framework of the biologically based two-stage clonal expansion (TSCE) model. It was found that about 2.6% of the 1854 solid cancer deaths (excluding 18 bone cancer cases) could be related to radiation exposure. At age 63, which is the mean age for solid cancer deaths, the excess relative risk (ERR) and excess absolute risk (EAR) were found to be 0.76 Gy(-1) (95% CI 0.23; 1.29) and 33.0 (10(4) PY Gy)(-1) (95% CI 9.8; 52.6), respectively. These risk estimates are consistent with earlier excess relative risk analyses for the same cohort. The change in the ERR with age was investigated in detail, and an increase in risk with attained age was observed. Furthermore, the data were tested for possible signs of genomic instability, and it was found that the data could be described equally well by a model incorporating effects of genomic instability. Results from the TSCE models indicated that radiation received at older ages might have stronger biological effects than exposure at younger ages.
Collapse
Affiliation(s)
- M Eidemüller
- GSF-National Research Center for Environment and Health, Institute of Radiation Protection, 85764 Neuherberg, Germany.
| | | | | | | | | |
Collapse
|
10
|
Ostroumova E, Gagnière B, Laurier D, Gudkova N, Krestinina L, Verger P, Hubert P, Bard D, Akleyev A, Tirmarche M, Kossenko M. Risk analysis of leukaemia incidence among people living along the Techa River: a nested case-control study. J Radiol Prot 2006; 26:17-32. [PMID: 16522942 DOI: 10.1088/0952-4746/26/1/001] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
Abstract
Large quantities of radioactive materials released over time from the Mayak nuclear weapons facility caused significant internal and external exposure for people living along the banks of the Techa River (Southern Urals, Russia). We conducted a nested case-control study in the Extended Techa River Cohort to determine whether the risk of leukaemia incidence increased with protracted exposure to ionising radiation or with other non-radiation risk factors. The study included 83 cases identified over 47 years of follow-up and 415 controls matched for sex, age at diagnosis, age (within a 5 year age group), and date of initial residence in the riverside area. External and internal doses have been calculated using the Techa River Dosimetry System 1996 (TRDS96). Conditional logistic regression was used to calculate odds ratios per Gray (OR/Gy) and 95% confidence intervals (95% CI). After excluding cases of chronic lymphoid leukaemia, the OR/Gy of total, external, and internal doses were 4.6 (95% CI: 1.7-12.3), 7.2 (95%CI: 1.7-30.0) and 5.4 (95%CI: 1.1-27.2), respectively. A history of solid tumour, either malignant or benign, before the leukaemia diagnosis was associated with a 2.5-fold increase in the leukaemia risk (95% CI: 1.1-5.9). Even though the analysis of confounders was less useful than expected because of missing data, multivariate analyses that took the exposure dose into account confirmed the association between leukaemia incidence and tumour history.
Collapse
Affiliation(s)
- E Ostroumova
- Urals Research Center for Radiation Medicine, Chelyabinsk, Russia
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Affiliation(s)
- M M Kossenko
- Urals Research Center for Radiation Medicine, Medgorodok, Chelyabinsk, Russian Federation
| | | | | | | |
Collapse
|